Care to AIDS patients: the cost impact on Medicare. NLM AIDSLINE Important note: Information in this article was accurate in 1986. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Care to AIDS patients: the cost impact on Medicare.

Caring. 1986 Jun;5(6):56-7. Unique Identifier : AIDSLINE AHA/86272474
Smith EW

Abstract: Medicaid is currently providing necessary services to approximately 40 percent of AIDS sufferers who have no other sources of payment and met eligibility requirements of the program. For those AIDS patients, states can exercise current Medicaid Program flexibility in adopting innovative delivery systems to provide high quality care in the most cost-effective setting. This will enable Medicaid-eligible AIDS sufferers to receive care in a wide range of settings and hopefully alleviate as much suffering as possible during the course of the disease. HCFA will continue to monitor the effects on Medicaid of care provided to AIDS patients by seeking current and relevant information from all available sources. This will enable us to better estimate the cost impact to the Medicaid program of providing care to Medicaid-eligible persons with AIDS.
Keywords: Acquired Immunodeficiency Syndrome/ECONOMICS/*THERAPY Human Medicaid/*ECONOMICS Medicare/*ECONOMICS United States United States Health Care Financing Administration JOURNAL ARTICLE

KWDacquiredimmunodeficiencysyndrome/economics/KWDtherapyhumanmedicaid/KWDeconomicsmedicare/KWDeconomicsunitedstatesunitedstateshealthcarefinancingadministrationjournalarticle
861130
M86B0226

Copyright © 1986 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1986. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1986. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .